Buradasınız

Anasayfa » Content

AİLESEL AKDENİZ ATEŞİ

FAMILIAL MEDITERRANEAN FEVER

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Aim: Familial Mediterranean fever, is the most common and well known disease in hereditary peri¬odic fever syndromes at the present time. In this review we summarized the disease, which was seen frequently in our country, and newly treatment methods. Main findings: Familial Mediterranean fever was described in a Jewish girl in 1908. Generally it was seen in Armenians, Sefaradian Jew, Arabians and Anatolian Turks. Pathogenesis of the disease was not clear. Characteristic feature of the disease is acute fever attacks accompanied with abdominal pain, chest pain and joint pain. The most important complication is type AA amiloidosis. There is no specific laboratory or radiological finding. Colchicum which is used in the treatment, decreases frequency of attacks and prevents from development of amiloidosis. Result: Aproximately 1/4 patients are resistive to colchicum treatment. There are some studies which shows adding interferon a, selective seratonine reuptake inhibitors and biological agents to the treatment are effective in these patients.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Ailesel Akdeniz Ateşi, günümüzde bilinen herediter periyodik ateş sendromları arasında en yaygın ve en iyi tanınmış olanıdır. Biz bu derlemede, yurdumuzda sıkça görülen bu hastalığı ve yeni tedavi metotlarını özetledik. Ana bulgular: Ailesel Akdeniz ateşi literatürde ilk defa 1908 yılında bir Yahudi kızında tanımlanmıştır. Çoğunlukla Ermenilerde, Sefarad Yahudilerinde, Araplarda, Anadolu Türklerinde görülür. Hastalığın patogenezi tam olarak aydınlatılamamıştır. Tipik özelliği karın ağrısı, göğüs ağrısı veya eklem ağrısının eşlik ettiği akut ateş ataklarıdır. En önemli komplikasyonu ise AA tipi amiloidozdur. Spesifik bir laboratuvar veya radyolojik bulgusu yoktur. Tedavide en çok kullanılan kolşisin, akut atak sıklığını azalttığı gibi amiloidoz gelişimini önlemede de etkindir. Sonuç: Hastaların yaklaşık 1/4'ü kolşisin tedavisine dirençlidir. Bu hastalarda tedaviye eklenen interferon a, selektif ser-atonin reuptake inhibitörleri veya biyolojik ajanların etkili olduğunu gösteren çalışmalar vardır.
FULL TEXT (PDF): 
PDF icon arastirmax-ailesel-akdeniz-atesi.pdf
  • 4
209-216
  • Turkish

REFERENCES

References: 

1. Lidar M, Kedem R, Mor A, Levartovsky D, Langevitz P, Livneh A. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol. 2005;32:859-62.
2. Pras M. FMF: Past, Present and Future. Clin Exp
Rheum 2002;20(suppl 26):66.
3. Marmaralı A. Garip bir karın sendromu. Türk Tıp
Cem Mecm 1946;12:436-3
4. Gilgil E, Arman M.i. Ailesel Akdeniz Ateşi. In Göksoy T. Ed Romatizmal Hastalıklarda Tanı ve Tedavi. Yüce yayınları, istanbul. 2002:711-20
5. Doğanavşargil E, Keser G. Ailesel Akdeniz Ateşi. In Doğanavşargil E; ed. Klinik Romatoloji. Deniz mat-baası; istanbul 1999;467-74
6. Gang N, Drenth JP, Langevitz P, Zemer D, Brezniak N, Pras M, et al. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol. 1999;
26:890-7.
7. Turkcapar N, Tuncali T, Kutlay S, Burhan BY, Kinikli G, Erturk S, Duman M. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the dis¬ease in the patients with familial Mediterranean fever.
Rheumatol Int. 2007;27:545-51
8. Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H.. Serum soluble intercellular adhesion mole-cule 1 and interleukin 8 levels in familial Mediterranean
fever. J Rheumatol. 1999;26:1983-6.

9. Haringman JJ, Ludikhuize J, Tak PP. Chemokines in
joint disease: the key to inflammation? Ann Rheum Dis
2004;63:1186-94
10. Dizdar O, Kalyoncu U, Karadag O, Akdogan A, Kiraz S, Ertenli I, et al. Macrophage inflammatory pro-tein-1-a: A link between innate immunity and familial mediterranean fever? Cytokine. 2007;30. [Epub ahead of print]
11. Ozgocmen S, Ozcakar L, Ardicoglu O, Kocakoc E, Kaya A, Kiris A. Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol. 2006;25:83-7.
12. Onen F. Familial Mediterranean Fever. Rheumatol
Int. 2006;26:489-96
13. Livneh A, Langevitz P. Diagnastic and treatment concerns in familial Mediterranean fever. Baillier's
Clinical Rheumatology. 2000;14:477-98
14. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.
Medicine (Baltimore). 2005;84:1-11.
15. Balaban B, Yasar E, Ozgul A, Dincer K, Kalyon TA. Sacroiliitis in familial Mediterranean fever and seroneg¬ative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int. 2005;25:641-4.
16. B'chir Hamzaoui S, Bouslama K, Abdallah M, M'rad R, M'rad S, Ben Dridi M. Myalgia in familial Mediterranean fever. Rev Neurol (Paris). 2007;163:93-
5

17. Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996;26:612-27
18. Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol. 2003;18:853-9
19. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, et al. MEFV mutation analysis in patients suf¬fering from amyloidosis of familial Mediterranean
fever. Amyloid 1999;6:1-6
20. Shimoni Y, Shalev E. Pregnancy and complicated familial Mediterranean fever. Int J Gynaecol Obstet.
1990;33:165-9.
21. Collard M, Sellal F, Hirsch E, Mutschler V,
Marescaux C. Recurrent aseptic meningitis in periodic
disease or Mollaret's meningitis? Rev Neurol (Paris).
1991;147:403-5.
22. Majeed HA, Ghandour K, Shahin HM. The acute
scrotum in Arab children with familial Mediterranean
fever. Pediatr Surg Int. 2000;16:72-4
23. Haimov-Kochman R, Prus D, Ben-Chetrit E.
Azoospermia due to testicular amyloidosis in a patient
with familial Mediterranean fever. Hum Reprod.
2001;16:1218-20.
24. Yalcinkaya F, Tumer N, Tulunay O, Tekin M. FMF related non-amyloid glomerular diseases. In: Sohar E, Gafni J, Pras M (eds) Proceedings of the 1st International Conference on FMF, Jerusalem, 1997. Freund, Tel Aviv, pp 175-80
25. Chetrit EB, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis
2003;62:916-9
26. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
27. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian fever Q J
Med. 1982;51:469-80
28. Goldfinger SE. Colchicine for familial
Mediterranean fever. N Engl J Med 1972;287:1302
29. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in pre¬venting attacks of familial Mediterranean fever. N Engl J Med 1974; 291: 932-4.
30. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum. 1998;28:48-59
31. Sherif AM, Refaie AF, Sheashaa HA, El-Tantawy AE, Sobh MA. Long term outcome of live donor kidney transplantation for renal amyloidosis. Am J Nephrol. 2004;24:582-6
32. Keven K, Sengul S, Kutlay S, Ekmekci Y, Anadol E, Nergizoglu G, Ates K, Erturk S, Erbay B Long-term out¬come of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center expe¬rience. Transplant Proc. 2004;36:2632-4.
33. Calguneri M, Apras S, Ozbalkan S, Ozturk MA, Ertenli I, Kiraz S. The efficacy of continuous interferon-a administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. Clin Exp Rheumatol. 2004;22(4 Suppl 34):41-4
34. Tunca M, Akar S, Soyturk M, Kirkali G, Resmi H, Akhunlar H, et al. The effect of interferon-a adminis-tration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial. Clin Exp
Rheumatol. 2004;22(4 Suppl 34): 37-40.
35. Ureten K, Calguneri M, Onat MA, Ozcakar L, Ertenli I, et al. Interferon alfa in protracted arthritis of familial Mediterranean fever: a robust alternative for synovec-
tomy. Ann Rheum Dis. 2004;63:1527
36. Onat AM, Ozturk MA, Ozcakar L, Ureten K, Kaymak SU, Kiraz S, et al Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever Tohoku J Exp Med. 2007;211:9-14.
37. Mor A, Pillinger MH., Kishimoto Abeles M, Livneh A, familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol. 2007;13:38-40

Thank you for copying data from http://www.arastirmax.com